Description
GBR-12909 is a potent and selective dopamine reuptake inhibitor (DRI). In a mouse model it has been found to increase activity and reduce spatial d in combination with increased exploratory behavior.
| Product Unit Size | Cost | Quantity | Stock |
|---|
GBR-12909 is a potent and selective dopamine reuptake inhibitor (DRI). In a mouse model it has been found to increase activity and reduce spatial d in combination with increased exploratory behavior.
| Cas No. | 67469-78-7 |
|---|---|
| Purity | ≥98% |
| Formula | C28H32F2N2O • 2HCl |
| Formula Wt. | 523.49 |
| Chemical Name | 1-(2-(bis(4-fluorophenyl)methoxy)ethyl)-4-(3-phenylpropyl)piperazine dihydrochloride |
| IUPAC Name | 1-[2-[bis(4-fluorophenyl)methoxy]ethyl]-4-(3-phenylpropyl)piperazine;dihydrochloride |
| Synonym | Vanorexine Dihydrochloride, Vanoxerine hydrochloride |
| Solubility | Slightly soluble in water ~2.5 mg/mL. Solubility in DMSO - >25 mg/mL. |
| Store Temp | Ambient |
|---|---|
| Ship Temp | Ambient |
| MSDS | |
|---|---|
| Info Sheet |
Andersen P. The dopamine inhibitor GBR 12909: selectivity and molecular mechanism of action. Eur J Pharmacol. 166(3):493-504 (1989). PMID: 2530094.
Young J, Goey A, Minassian A, et al. GBR 12909 administration as a mouse model of bipolar disorder mania: mimicking quantitative assessment of manic behavior. Psychopharmacology (Berl). 2010 Feb;208(3):443-454. PMID: 20020109.
HDAC1/2/3/11 inhibitor.
Phenol found in Zingiber; 5-HT3 antagonist.
Glucose metabolism inhibitor, N-linked glycosyl...
Steroidal saponin found in Tribulus, Trigonella...
Alkaloid found in Corydalis and Stephania; D1/2...
Opioid peptide; δOR agonist.
Synthetic analog of 1,4-naphthoquinone, precurs...
FGFR inhibitor.
STING inhibitor
Triterpenoid
Anthraquinone found in various plant sources; C...
Endogenous opioid peptide derived from the β-c...
LRRK2 inhibitor.
Inhibits HCV replication
Benzimidazole; microtubule polymerization inhib...
Impurity of everolimus
Resveratrol prodrug; potential SIRT1 activator....
Vitamin E component
Fluorouracil impurity
CDK2 inhibitor